A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SCTV01C in Population Aged ≥18 Years and Previously Fully Vaccinated With COVID-19 Vaccine
Clinical trial NCT05238454 · UNKNOWN
Trial details
- NCT number
- NCT05238454
- Sponsor
- Sinocelltech Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-20
- Primary completion
- 2022-07-01
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.